We have demonstrated previously that the human picornavirus Echovirus 1 (EV1) triggers an infectious internalization pathway that follows closely, but seems to stay separate, from the epidermal growth factor receptor (EGFR) pathway triggered by epidermal growth factor (EGF). Here, we confirmed by using live and confocal microscopy that EGFR and EV1 vesicles are following intimately each other but are distinct entities with different degradation kinetics. We show here that despite being sorted to different pathways and located in distinct endosomes, EV1 inhibits EGFR downregulation. Simultaneous treatment with EV1 and EGF led to an accumulation of EGFR in cytoplasmic endosomes, which was evident already 15 min p.i. and more pronounced after 2 hr p.i. EV1 treatment led to reduced downregulation, which was proven by increased total cellular amount of EGFR. Confocal microscopy studies revealed that EGFR accumulated in large endosomes, presumably macropinosomes, which were not positive for markers of the early, recycling, or late endosomes/lysosomes. Interestingly, EV1 did not have a similar blocking effect on bulk endosomal trafficking or transferrin recycling along the clathrin pathway suggesting that EV1 did not have a general effect on cellular trafficking pathways. Importantly, EGF treatment increased EV1 infection and increased cell viability during infection. Simultaneous EV1 and EGF treatment seemed to moderately enhance phosphorylation of protein kinase C α. Furthermore, similar phenotype of EGFR trafficking could be produced by phorbol 12-myristate 13-acetate treatment, further suggesting that activated protein kinase C α could be contributing to EGFR phenotype. These results altogether demonstrate that EV1 specifically affects EGFR trafficking, leading to EGFR downregulation, which is beneficial to EV1 infection.
| INTRODUCTION
We have shown previously that the members of enterovirus group B viruses such as Echovirus 1 (EV1) and coxsackievirus A9 trigger their own entry pathway to cells (Karjalainen et al., 2008; Karjalainen et al., 2011; Marjomäki et al., 2002; Pietiäinen et al., 2004; Rintanen et al., 2012; Upla et al., 2004; Heikkila et al., 2010; Huttunen, Waris, Kajander, Hyypia, & Marjomaki, 2014) . This involves clathrin-independent and macropinocytosis-like entry to endosomes, which quickly develop into neutral multivesicular bodies (MVBs) . Similarly, the epidermal growth factor receptor (EGFR) uses a partially similar kind of macropinocytic entry and delivery to MVBs. The greatest difference of the nature of their MVBs is the fact that enterovirus and endosomes do not acidify (Karjalainen et al., 2011; Rintanen et al., 2012; Huttunen et al., 2014) and avoid targeting to the lysosomes, whereas EGFR is efficiently taken to acidic lysosomes for degradation (Wiley et al., 1991) . Thus, these two endosomal populations have different fates in the cell despite the morphological similarity of the endosomes.
Echovirus 1 like many other enteroviruses uses common cell surface protein, such as an integrin (α2β1 integrin) as its cellular receptor.
Specific plasma membrane (PM) domains, like lipid rafts, have been shown to gather both adhesion receptors and growth factor receptors to the same PM regions leading to close association between, for example, α2β1 integrin and the EGFR (Ivaska & Heino, 2011) . EV1 receptor α2β1 integrin resides very close to EGFR on the PM and have been shown to collaborate at different levels and even co-immunoprecipitate with each other (Yu, Miyamoto, & Mekada, 2000; Moro et al., 2002; Mattila et al., 2005) .
The EGFR plays an important role in essential cellular functions such as cellular proliferation and migration. Conformational change, caused by ligand (EGF) binding, activates the receptor and leads to receptor dimerization and internalization (Ogiso et al., 2002) . The activation of EGFR leads to accelerated internalization and degradation of the receptor in lysosomes (Wiley et al., 1991) . This receptor downregulation is the major negative feedback regulatory mechanism that controls the intensity and duration of receptor signaling (Wells et al., 1990) , although EGF-receptor complexes are suggested to remain active and to signal also in endosomes (Wiley, 2003; Platta & Stenmark, 2011) . EGFR activation has been shown to lead to efficient internalization through both clathrin and clathrin-independent pathways (Wiley, 1988; Sorkin & Goh, 2008; Lund et al., 1990) . It has also been suggested that stimulation with a high EGF concentration leads to macropinocytic internalization of EGFR (Hewlett, Prescott, & Watts, 1994; Hamasaki, Araki, & Hatae, 2004; Liberali et al., 2008) . Despite the internalization pathway, equilibrium between receptor recycling and degradation balances the EGFR availability and signaling.
We have previously shown that the triggered enterovirus-endocytosis pathway leads to downregulation of its receptor integrin with clearly slower kinetics than the degradation of EGFR (Marjomäki et al., 2002; Pietiäinen et al., 2004; Upla et al., 2004; Karjalainen et al., 2008; Karjalainen et al., 2011; Rintanen et al., 2012) . EGFR shows much faster downregulation in acidic Lamp1-positive lysosomes in contrast to much slower degradation of α2β1 integrin in more neutral MVBs that do not contain canonical endosomal markers (Rintanen et al., 2012) .
Here, we show that despite the fact that EV1 and EGF trigger entry to distinct endosomes, EV1 has a clear negative regulatory effect on EGFR downregulation. We show that EV1 causes an accumulation of endosomal EGFR and delayed downregulation of EGFR.
| RESULTS

| EV1 treatment leads to accumulation of EGFR in the cytoplasm
On the cell surface, EGFR has been shown to reside close to the EV1 receptor, α2β1 integrin, and to even co-immunoprecipitate together (Yu et al., 2000; Moro et al., 2002; Mattila et al., 2005) . Here, we followed the internalization of EGFR elicited during EV1 infection and EGF stimulation. After starving the cells for 2 hr in serum-free medium, the cells were treated with cycloheximide (to inhibit the protein synthesis), EGF (100 ng/ml), and EV1. After 15 min and 2 hr incubations, the infected cells were labeled with antibodies against EGFR and EV1. Confocal fluorescence microscopy showed that after 15 min, both EV1 and EGFR were located in the cell periphery in a high number of vesicles ( Figure 1a) . After 2 hr, the EGFR structures were less numerous but closer to the cell center, as expected. After 2 h internalization, EGFR is suggested to undergo degradation leading to a reduction of the EGFR signal.
The location of EV1 was often very close to the EGFR vesicles after 15 min, but after 2 hr, EV1 was still more scattered and more clearly separated from EGFR vesicles (Figure 1a) . Colocalization analysis between EV1 and EGFR showed that approximately 30% of the signals had overlap with each other. The overlap of the vesicles seemed very marginal in the images, suggesting that the colocalization may be biased by the close proximity of the vesicles and limited resolution. After 2 hr time point, the quantified colocalization was clearly reduced, about 18%, probably because the stronger movement of EGFR to the perinuclear region in comparison with EV1 separated the vesicles more efficiently, leading to smaller amount of false colocalization ( Figure 1b) . The labeling of EGFR in cells without EV1 treatment showed similar localization of vesicles after 15 min and 2 hr (Figure 1c) . However, the images suggested that during EV1 treatment, EGFR showed higher intensity after 2 hr than without EV1.
Quantification of the EGFR signal after 15 min and 2 hr with or without EV1 showed clear differences in the fate of EGFR: Without EV1, the EGFR signal dropped to about half of the original signal, whereas during EV1 treatment, the EGFR signal accumulated in vesicles leading to doubling of the intensity in vesicles (Figure 1d ).
In order to further confirm the effect on EGFR, we triggered the virus pathway by clustering the receptor by antibodies in another cell line, SAOS-α2β1 cells. We have shown before that the receptor clustering with antibodies faithfully mimics virus-induced integrin clustering and internalization to the cells Karjalainen et al., 2008) . In addition to the typically used high amount of EGF (100 ng/ml), we also wanted to verify if this effect on EGFR would also occur with a lower amount (1 ng/ml). We followed the EGFR signal after virus receptor clustering for 15 min and 2 hr (Figure 1e ). With both doses of EGF, the EGFR signal stayed approximately 2.5-fold higher after 2 h with receptor clustering, whereas the EGFR signal reduced in both cases without clustering (Figure 1e ). The results thus showed that EGFR accumulation was observed with antibody-induced receptor clustering and with both low and high EGF amounts, although different signal intensities were gained due to the different cell types used. However, the intensity of EGFR signal in the vesicles internalized for 15 min was higher with the higher EGF dose. Interestingly, receptor clustering via both EV1 treatment and antibodies also reduced the internalized amount after 15 min, suggesting that in addition to EGFR signal accumulation in the cytoplasm, these treatments reduced the uptake of EGFR during EGF signaling (Figure 1d ,e).
Earlier, we had observed moderate increases of viral infection by adding EGF and comparing with a full serum control (Karjalainen et al., 2011) . Here, after overnight starvation, low (0.1 nM) and high 
| EV1 and EGFR pathways are separate after internalization
We next set out to perform live imaging of the vesicle populations in order to more dynamically observe the two vesicle populations and study their association in more detail. As it was easier to follow the virus pathway dynamically by labeling its receptor, we set out to cluster the virus receptor α2 integrin with the clustering fluorescent secondary antibody as described before (Karjalainen et al., 2008 ; see also the Materials and Methods section). We followed the clustered 
| EV1 treatment slows down EGFR downregulation
As the EGFR signal seemed to stay higher during virus and receptor internalization, we set out to study the EGFR signal in more detail.
We first monitored the effect of EV1 on EGFR internalization without additional EGF stimulation. We infected serum-starved (and cyclohex- (Figure 3c ). However, due to the high variation in the case of EV1, the result was not statistically different from the control situation. The quantified intracellular pool after EV1 treatment was significantly higher (p = 0.006) than after EGF alone at 2 hr p.i. (Figure 3d ). In addition, during EGF stimulation, EV1 caused a higher pool of EGFR to accumulate in the cytoplasm after 2 h compared with EGF stimulation only (p = 0.011) ( Figure 3d ). As there was no increase of the surface EGFR pool due to EV1 after 2 and 4 hr treatments (Figure 3c ), it indicates that the increase of the intracellular EGFR pool during EV1 treatment was most probably due to slowing down of the intracellular EGFR degradation.
In conclusion, although EV1 and EGFR were not internalized into the same endocytic structures, EV1 nevertheless had an effect on the turnover of EGFR by decelerating the degradation of EGFR.
2.4 | EV1 treatment has no effect on transferrin recycling or overall fluid phase uptake As EV1 may have affected the cellular trafficking in a more general manner, we wanted to study if EV1 had an effect on major endocytosis and recycling pathways. We then continued checking if the entry to the lysosomal pathway was affected by EV1 by following the fluid phase entry of mouse IgG. The early part of the fluid phase uptake pathway from the cell surface to the sorting early endosomes is shared by receptors on the clathrin pathway, for example, TF receptor. If there would be changes in the early uptake, it would be seen also in the levels of IgG uptake.
After internalization, IgG molecules are either recycled back to PM or downregulated in lysosomes (Ward, Zhou, Ghetie, & Ober, 2003) . We were interested if EV1 infection had any effect on the overall trafficking and fate of IgG. A high dose of IgG (1 mg/ml) was added on cells Altogether, these results suggest that EGFR trafficking follows the same endosomal pathway with or without EV1 treatment. EGFR is targeted to Lamp1-positive lysosomes largely via macropinocytosis as has been shown before and therefore may bypass the classical early and late endosomes prior to lysosomes. However, we noticed a small reduction in the amount of EGFR associated with the lysosomal marker, suggesting a reduced delivery to the lysosomes for degradation.
| EV1 showed minor effects on EGFR signaling
As it was obvious that EV1 was not physically associated with EGFR during internalization, we set out to explore common signaling pathways associated both with EV1 and EGFR trafficking. Protein kinase C (PKC) is one of the key signaling enzymes mediating EGFR activation, and as we have shown previously, PKCα is also mildly activated by EV1-induced integrin clustering in the presence of low amount of serum . By sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting, we found that EGF induced the cellular phosphorylation status of PKCα as expected (Figure 6a ). Without EGF stimulation (or serum addition), EV1 could not much induce PKCα As a control, we also tested the direct effect of PKC activation on EGFR vesicles using phorbol 12-myristate 13-acetate (PMA) as a pan-PKC activator. PMA was not able to induce internalization and accumulation of EGFR without EGF stimulation in starved cells (data not shown).
However, in the presence of EGF stimulation, PKC activation increased uptake of EGFR and also retained approximately the same EGFR signal in the cytoplasmic vesicles even after 2 hr, whereas without PMA, the EGF signal typically was greatly reduced (Figure 6d ). These results thus suggest that the increased PKC activation is contributing to the accumulation of EGFR in the cytoplasm and is analogous to what we see during a combined treatment of EV1 and EGF stimulation.
| DISCUSSION
We showed in this study that the human pathogen, EV1, has a specific effect on EGFR internalization pathway while its effects are negligible on TF recycling or fluid phase uptake via the clathrin pathway. How could EV1 effect EGFR pathway with such specificity, and how could it exert its effect as the virus and EGFR stay in separate endosomal populations after internalization?
The EV1 uses α2β1 integrin as its cellular receptor (Bergelson, Shepley, Chan, Hemler, & Finberg, 1992) . EV1 clusters the integrin FIGURE 4 Echovirus 1 (EV1) treatment has no effect on transferrin recycling or fluid phase uptake. (a) Analysis of colocalization between the internalized Alexa488-labeled transferrin (green) (0.25 mg/ml) and the early endosomal marker EEA1. After a pulse of transferrin for 30 min and a chase for 2 or 4 hr, the colocalization was quantified from confocal images. Altogether, 10 cells from two independent experiments were quantified. Ctrl stands for a 30 min pulse without EV1 and "0′ + 30´" stands for the 30 min pulse with EV1. Blow-up images show in greater detail the distribution of internalized transferrin and EEA1. (b) A high amount of mouse IgG (1 mg/ml) was added in cells for a 15 min pulse and then chased for 20 min at 2 and 4 hr time points of EV1 treatment. Internalized IgG was detected by anti-mouse Alexa 488 conjugates and quantified. Examples of control cells and cells after EV1 treatment for 2 hr are on the left. The experiment was done two times, and 40 cells were quantified from confocal images. Scale bars, 10 μm upon binding to several I domains of nearby integrins on the cell surface, which in turn causes an efficient internalization of the virusreceptor complex to peripheral endosomes (Marjomäki et al., 2002; Pietiäinen et al., 2004; Upla et al., 2004; Karjalainen et al., 2008; Karjalainen et al., 2011; Rintanen et al., 2012) . On the cell surface, EGFR has been shown to co-immunoprecipitate integrins such as α2β1 integrin, demonstrating how closely they are connected on the plasma membrane (Yu et al., 2000; Moro et al., 2002; Mattila et al., 2005) . Integrins in general have been shown to orchestrate growth factor receptor endocytosis and trafficking and leading to effects on their signaling (Caswell et al., 2008; Caswell, Vadrevu, & Norman, 2009 ). Previously, integrins were suggested to function as negative regulators for EGFR signaling (Mattila et al., 2005) . From our data, it was clear that without EGF stimulation, EV1 treatment shown in previous studies using quantitative confocal microscopy that the EV1 internalization pathway stays outside the acidic lysosomal clathrin pathway, whereas EGFR is targeted to lysosomal degradation (Rintanen et al., 2012; Wiley et al., 1991) . When we measured the intraendosomal pH of virus and integrin-containing vesicles, we observed pH close to neutral values, whereas EGFR-containing endosomes showed much lower pH values already after 1 and 2 hr post-internalization, further demonstrating that EV1 and EGFR reside in distinct endosomes (Rintanen et al., 2012; Karjalainen et al., 2011) . However, in case a different pH and degradation kinetics could be maintained at different domains of an organelle, it still remains a possibility that EV1 and EGFR could travel in a larger organelle if the various domains could be kept quite distinct from each other. We were not able to see any apparent accumulation of EGFR in conventional early and late endosomes, suggesting that trafficking to lysosomes in our study occurred mostly via macropinosomes as has been suggested before . However, we did notice a small decrease of EGFR targeting to the lysosomal compartment, further suggesting that EGFR was halted in endosomes before the degradative lysosomes.
The observed block in EGFR degradation could be best explained by the tentative activation and effects through PKCα. It was shown previously that PKC activation using the pan-activator PMA causes a degradation defect in EGFR through increased phosphorylation of Thr654 in EGFR (Bao et al., 2000) . We have shown already in our earlier studies that α2β1 integrin clustering induced by EV1 infection or antibody treatment increases mildly the PKCα activation (Turkki et al., 2013; Upla et al., 2004) . Importantly, in this study, we could reproduce the EGFR accumulation in endosomes and reduced degradation using the PMA treatment, suggesting that the observed effects could be due to PKC activation. As we also observed retarded targeting of EGFR to Lamp1-positive lysosomes, it thus seems probable that EV1 infection causes a block in the lysosomal targeting due to PKC activation in the close vicinity of EGFR.
Why would EV1 have evolved to induce prolonged EGF localization and tentatively prolonged signaling in cells during viral infection? Enteroviruses have a rather short life cycle producing viral particles and cell lysis during 6 to 10 hr p.i. In order to optimize the virus production with proper timing for cell lysis, it may be beneficial to manipulate both the pro-survival and pro-apoptotic pathways in a right order (Cooray, 2004) . This may explain the fact that both kinds of pathways have been linked to enterovirus infection with various effects during early or late infection. Akt activation has been found beneficial for both Coxsackievirus B3 and enterovirus 71 (EV1), while inhibition of Akt signaling was shown to lead to premature apoptosis and lysis of cells (Esfandiarei et al., 2004; Wong, Chen, Yang, Chen, & Horng, 2005; Zhang et al., 2014) . Indeed, for EV1, EGF stimulation increased both the number of infected cells and kept higher ATP levels in cells, suggesting that prolonged EGF localization in endosomes is beneficial for EV1.
Altogether, our results here show that EV1 internalization leads to reduced downregulation of the receptor due to inhibited targeting to the lysosomes. These phenomena may be acted via PKCα because PKC activation has been reported to divert EGFR from the degradation pathway to the recycling pathway (Bao et al., 2000) , and this phenotype was reproduced by PMA or combined EV1/EGF treatments in this study. Furthermore, based on higher cell viability and increased number of infected cells, EV1 was shown to benefit from EGF stimulation. Technologies, Paisley, UK) containing 5% fetal bovine serum (FBS, Life Technologies), supplemented with penicillin and streptomycin (Life Technologies). Experiments were also performed using a human osteosarcoma cell line, overexpressing the α2 integrin subunit (SAOS-α2β1 cells, clone 45) as described previously (Siljamaki et al., 2013) . The levels of α2β1 in both these cell lines are rather comparable (See Supplementary Figure 1 in Siljamaki et al., 2013) . EV1 (Farouk strain; ATCC) was produced and purified as described previously (Marjomäki et al., 2002) . Culture medium for virus infections was supplemented with 1% FBS. For all infection studies, MOI 100 was used. Typically, it leads to 50-70% infection in the A549 cells at 6 hr p.i. without cycloheximide treatment. Serum starvations were done in DMEM without adding any FBS or antibiotics (0% DMEM). EGF stimulations were done with 100 ng/ml EGF (Molecular Probes, product number E-3476, Life Technologies) in the presence of cycloheximide (10 μg/ml, Sigma-Aldrich C7698, Helsinki, Finland).
The following antibodies were used: rabbit antisera against purified EV1 (Marjomäki et al., 2002) 
| Cell viability tests
Cell viability was measured from infected cells in 96 well plates using a Cell Titre Glo assay (Promega, Southampton, UK) according to manufacturer's instructions. Luminescence was read with Victor X4 2030 multiplate reader (Perkin Elmer).
| Immunofluorescence and Confocal Microscopy
A549 cells were grown on coverslips to subconfluency. The cells were serum-starved for 2 hr in 0% DMEM after which they were incubated with or without EGF (100 ng/ml) and/or EV1. After incubation at 37°C, the cells were fixed with 4% PFA for 20 min, permeabilized with 0.2%
Triton X-100 (TX-100) for 5 min, and stained with antibodies (dilutions made in 3% bovine serum albumin-PBS). In the surface labeling assay, EGFR was labeled with primary and secondary antibodies prior to the permeabilization. The cells were mounted in ProLong® Gold antifade reagent with DAPI (4',6-Diamidine-2'-phenylindole dihydrochloride) and examined with an Olympus microscope IX81 with a FluoView-1000 confocal setup. Levels for the laser power, detector amplification, and optical sections were optimized for each channel before starting the imaging. 
| Image analysis and statistical testing
An open-source software package, BioImageXD (Kankaanpää et al., 2012) , was used for the confocal and widefield image colocalization and intensity quantifications. MATLAB method described in Ruusuvuori et al. (2014) was used for the association analyses.
To quantify the level of colocalization, at least 30 cells from three independent experiments, 10 cells from each, were randomly selected and optically sectioned by using a confocal microscope. Colocalization was visualized from the projection of the cell by examination of the merged images and quantified with the BioImageXD software. The images were preprocessed with a difference of Gaussian filter to remove noise and enhance regions of interest before the colocalization analysis. Thresholds for the analysis were adjusted manually to eliminate fluorescence originating from the background and from diffuse staining. Signal overlap was expressed separately for both of the channels, as a proportion of the intensity colocalizing with the other channel. Statistical significance of observed colocalization was calculated by using the Costes algorithm, embedded within the software, and only colocalizations with zero coincidence probabilities were taken into account (i.e., p = 1.00).
For measuring the intensities of the vesicles, a multistep segmentation protocol implemented within the BioImageXD software was used. Images were first smoothed with the Gaussian filter and binarized by using an adaptively calculated threshold value (mean + 5) from 10 lateral pixel-size radius regions. Objects were defined using the Euclidean distance transform and watershed transform. Finally, all objects of sizes smaller than 5 voxels were removed from the analysis to remove noise and small debris.
Live imaging experiment data were preprocessed with difference of Gaussian filter and thresholded with Otsu thresholding to provide masks for both of the channels. Colocalization was directly measured using the signal inside the masks. For association measurements, individual objects were first labeled using connected component labeling.
The centroid of each object was then extracted for association analysis. The association was measured with the point pattern matching association method (Ruusuvuori et al., 2014) that finds optimal matching between two point sets, in this case the two sets of object centroids extracted from the images. The maximum distance between two points considered associating was set to 1200 nm. The association ratio was calculated as the ratio of the number of associating objects to the number of all objects in the channel.
A t-test was used for pairwise statistical comparison between samples. For percentages or ratio figures, t-test was applied after arcsin √ transformation of the original variable to convert the binomial distribution of the data to follow normal distribution.
| SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotting
Samples were prepared like described above (immunofluorescence and confocal microscopy). After the incubations, cells were scraped into Laemmli buffer and proteins were separated using 7.5% sodium 
